Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor

Abstract Cannabidiol (CBD), the major non-psychotomimetic compound present in the Cannabis sativa plant, exhibits therapeutic potential for various human diseases, including chronic neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, ischemic stroke, epilepsy and other convulsive syndro...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	María Rodríguez-Muñoz, Yara Onetti, Elsa Cortés-Montero, Javier Garzón, Pilar Sánchez-Blázquez
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2018-09-01
Saila:	Molecular Brain
Gaiak:	Cannabidiol Cannabinoids Sigma 1 receptor NMDA receptor Neuropathology Epilepsy
Sarrera elektronikoa:	http://link.springer.com/article/10.1186/s13041-018-0395-2
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!